What is the appropriate workup and treatment for microcytic anemia?

Workup and Treatment of Microcytic Anemia

Begin with serum ferritin measurement as the first-line diagnostic test, followed by a systematic algorithmic approach based on iron studies to differentiate between iron deficiency anemia (the most common cause), thalassemia trait, anemia of chronic disease, and rare genetic disorders of iron metabolism or heme synthesis. 1, 2

Initial Diagnostic Approach

Step 1: Confirm Microcytosis and Measure Ferritin

• Microcytic anemia is defined as MCV <80 fL in adults with hemoglobin <130 g/L in men or <120 g/L in non-pregnant women 1
• Mean corpuscular hemoglobin (MCH) may be more sensitive than MCV for detecting iron deficiency, as it's less affected by chronic disease and more reliable across different analyzers 1
• Serum ferritin <15 μg/L is highly specific (99%) for iron deficiency; ferritin <45 μg/L has 92% specificity and is reasonable for investigation, especially with inflammation 1

Step 2: Interpret Iron Studies Systematically

If ferritin is low (<15-45 μg/L):

• Diagnose iron deficiency anemia
• In adults, presume gastrointestinal blood loss until proven otherwise and investigate for GI malignancy 2
• Consider investigation at any level of anemia with iron deficiency, though more severe anemia (Hb <110 g/L in men, <100 g/L in women) has stronger indication 1

If ferritin is elevated but inflammation is present (elevated CRP):

• Ferritin <150 μg/L may still represent iron deficiency despite inflammation 1
• Measure reticulocyte hemoglobin content or soluble transferrin receptor to distinguish functional from absolute iron deficiency 1
• The [sTfR/log10 ferritin] ratio provides superior discrimination in chronic disease 1

If ferritin is normal/high with low iron and low TIBC:

• Consider anemia of chronic disease 2

Step 3: Rule Out Thalassemia

If MCV is disproportionately low relative to anemia severity with normal iron studies:

• Perform hemoglobin electrophoresis, particularly in patients of Mediterranean, African, Middle Eastern, or Southeast Asian descent 1, 2
• Beta-thalassemia trait typically shows elevated hemoglobin A2 levels 2
• MCV typically <65 fL suggests thalassemia over iron deficiency 2

Treatment Based on Etiology

Iron Deficiency Anemia

Standard treatment:

• Oral iron supplementation is first-line for uncomplicated cases 3
• Intravenous iron for severe anemia, intolerance to oral iron, malabsorption, or heart failure 3
• Pregnant patients and those with heart failure require special consideration for IV iron to prevent morbidity 3

Genetic Disorders (When Common Causes Excluded)

For X-linked sideroblastic anemia (XLSA) with ALAS2 defects:

• Initial treatment: pyridoxine 50-200 mg daily (occasionally up to 300 mg in overweight/elderly patients) 4
• If responsive, maintain with pyridoxine 10-100 mg daily lifelong (avoid excessive doses due to neurotoxicity risk) 4
• Monitor iron parameters (ferritin, transferrin saturation), liver enzymes, and screen for hepatocellular carcinoma 4
• Treat iron overload preferably with phlebotomies 4

For severe microcytic sideroblastic anemia in children (SLC25A38 defects):

• Hematopoietic stem cell transplantation is the only curative option 4
• Symptomatic treatment: erythrocyte transfusions and chelation therapy 4

For hypotransferrinemia (TF defects):

• Transferrin supplementation via plasma transfusion or apotransferrin infusion 4
• Monitor iron status; use phlebotomies for iron overload (chelation if phlebotomies not tolerated) 4

For SLC11A2 defects (childhood presentation with increased transferrin saturation):

• Treat with oral iron supplementation and/or EPO and/or erythrocyte transfusions based on individual needs 4
• Monitor iron status closely; consider liver MRI as normal ferritin doesn't exclude liver iron loading 4

Critical Pitfalls to Avoid

• Don't assume all microcytic anemia is iron deficiency—failure to respond to iron therapy demands immediate reassessment 5
• In older adults with iron-refractory microcytic anemia and discordant iron indices (iron loading with impaired utilization), perform bone marrow Perls staining to identify ring sideroblasts 5
• 40% of hospitalized patients with microcytic anemia receive inadequate follow-up testing—implement systematic protocols 6
• When ferritin is inconclusive due to inflammation (26% of cases), reticulocyte hemoglobin or sTfR testing is frequently omitted—don't skip these 6
• In suspected thalassemia (55% of cases), hemoglobin variant testing is often not performed—this is essential before labeling as iron deficiency 6
• Consider congenital erythropoietic porphyria (CEP) with X-linked GATA1 defects in severe microcytic hemolytic anemia with photosensitivity—allogeneic HSCT is curative 4

Special Populations

Older adults:

• Often have mixed mechanisms (both absolute and functional iron deficiency) due to polymorbidity/polypharmacy 7
• Nonspecific presentations (delirium, falls, cognitive disorders, apathy) may predominate 7
• Transfusion thresholds: <7 g/dL if asymptomatic, <8 g/dL with heart failure/coronary disease, <10 g/dL with poor tolerance 7
• Administer IV furosemide after transfusion to prevent transfusion-associated circulatory overload 7